Haoxi Health Technology Limited(HAO)Earnings, Financials & Key Ratios
HAO•NASDAQ
0.9× P/E·Price updated Jun 19, 2026
SectorCommunication ServicesIndustryAdvertising & MarketingSub-IndustryPerformance and commerce marketing
AboutHaoxi Health Technology Limited, through its subsidiaries, provides online marketing solutions in China. It offers online marketing solutions, including online short video marketing solutions to advertisers through its media partners; and customized marketing solutions by planning, producing, placing, and optimizing online ads to help advertisers acquire, convert, and retain consumers on various online media platforms. The company places its ads through mainstream online short video and social media platforms, such as Toutiao, Douyin, WeChat, and Sina Weibo. It serves advertiser client base primarily in the healthcare industry. The company was founded in 2018 and is based in Beijing, China.Show more
- Revenue$33M-32.4%
- EBITDA-$2M-194.2%
- Net Income$4M+200.1%
- EPS (Diluted)1.32+24.5%
- Gross Margin2.83%-50.1%
- EBITDA Margin-4.96%-239.4%
- Operating Margin-6.1%-272.3%
- Net Margin11.82%+343.9%
- ROE27.06%+34.5%
HAO Key Insights
Haoxi Health Technology Limited (HAO) fundamental analysis — strengths, weaknesses & financial health based on data analysis
✓Strengths
- ✓Excellent 3Y average ROE of 657.0%
- ✓Share count reduced 80.4% through buybacks
- ✓Trading at only 0.2x book value
- ✓Efficient asset utilization: 1.5x turnover
✗Weaknesses
- ✗Negative free cash flow
- ✗Weak momentum: RS Rating 0 (bottom 0%)
- ✗Trading more than 30% below 52-week high
* These insights are generated automatically based on available financial data. Please conduct your own research before making investment decisions.
Get notified when HAO posts new earnings or crosses analyst targets
Free. No account needed. Unsubscribe any time.
HAO Price & Volume
Haoxi Health Technology Limited (HAO) stock price & volume — 10-year historical chart
Loading chart...
HAO Growth Metrics
Haoxi Health Technology Limited (HAO) revenue, earnings & EPS growth — 3, 5 & 10-year CAGR
Revenue CAGR
10 Years-
5 Years-
3 Years26.63%
TTM53.23%
Profit CAGR
10 Years-
5 Years-
3 Years151.19%
TTM-233.6%
EPS CAGR
10 Years-
5 Years-
3 Years280.3%
TTM-149.39%
Return on Capital
10 Years192.82%
5 Years192.82%
3 Years192.82%
Last Year-13.63%
HAO Peer Comparison
Haoxi Health Technology Limited (HAO) competitors in Performance and commerce marketing — business model, growth, and fundamentals comparison
| Company | Market Cap | Stock Price | P/E Ratio (TTM) | Revenue Growth 1Y | Net Margin | Return on Equity (ROE) | FCF Yield | Debt / Equity |
|---|---|---|---|---|---|---|---|---|
 BTBT | 706.64M | 2.17 | -7 | -30.65% | -146.01% | -0.11% | 0.16 | |
 CLPS | 27.8M | 0.99 | -3.82 | 15.17% | -1.27% | -6.06% | 0.59 | |
 AIXI | 3.31M | 6.26 | -0.04 | -82.47% | -140.37% | |||
 RCON | 10.03M | 0.50 | -0.72 | -3.73% | -64.25% | -9.15% | 0.08 | |
 CNET | 3.27M | 1.00 | -1.49 | -70.11% | -33.27% | -28.25% | 0.04 | |
 GXAI | 8.69M | 1.22 | -2.22 | 479.02% | -131.27% | -34.42% | ||
 KXIN | 4.84M | 4.40 | -0.10 | -100% | -694.94% | -5.94% | 0.08 | |
 BIDU | 38.01B | 111.76 | 64.26 | -3.04% | 3.48% | 0.21% | 0.34 |
Compare HAO vs Peers
Haoxi Health Technology Limited (HAO) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.
HAO Income Statement
Haoxi Health Technology Limited (HAO) annual income statement — 10-year revenue, gross profit & net income history
10Y historyFree accessUpdated daily
| Metric | Jun'21 | Jun'22 | Jun'23 | Jun'24 | Jun'25 | TTM |
|---|---|---|---|---|---|---|
Sales/Revenue | 12.85M | 16.16M | 28.23M | 48.52M | 32.8M | 91.65M |
Revenue Growth % | - | 25.76% | 74.72% | 71.88% | -32.39% | 53.23% |
Cost of Goods Sold | 12.24M | 15.51M | 26.17M | 45.77M | 31.88M | 87.58M |
COGS % of Revenue | 95.29% | 95.98% | 92.7% | 94.33% | 97.17% | - |
Gross Profit | 605.58K▲ 0% | 648.72K▲ 7.1% | 2.06M▲ 217.9% | 2.75M▲ 33.4% | 927.75K▼ 66.3% | 4.07M▲ 0% |
Gross Margin % | 4.71% | 4.02% | 7.3% | 5.67% | 2.83% | 4.44% |
Gross Profit Growth % | - | 7.12% | 217.87% | 33.38% | -66.27% | - |
Operating Expenses | 275.02K | 379.95K | 866.25K | 1.03M | 2.93M | 10.85M |
OpEx % of Revenue | 2.14% | 2.35% | 3.07% | 2.13% | 8.92% | - |
Selling, General & Admin | 212.38K | 277.43K | 808.09K | 953.14K | 2.85M | 10.66M |
SG&A % of Revenue | 1.65% | 1.72% | 2.86% | 1.96% | 8.68% | - |
Research & Development | 62.65K | 102.52K | 58.16K | 79.98K | 79.54K | 189.86K |
R&D % of Revenue | 0.49% | 0.63% | 0.21% | 0.16% | 0.24% | - |
Other Operating Expenses | 0 | 0 | 0 | 0 | 0 | 0 |
Operating Income | 330.55K▲ 0% | 268.77K▼ 18.7% | 1.2M▲ 344.9% | 1.72M▲ 43.6% | -2M▼ 216.5% | -6.13M▲ 0% |
Operating Margin % | 2.57% | 1.66% | 4.24% | 3.54% | -6.1% | -6.69% |
Operating Income Growth % | - | -18.69% | 344.92% | 43.61% | -216.46% | - |
EBITDA | 330.96K | 270.98K | 1.2M | 1.73M | -1.63M | -5.86M |
EBITDA Margin % | 2.58% | 1.68% | 4.27% | 3.56% | -4.96% | -6.39% |
EBITDA Growth % | - | -18.12% | 344.38% | 43.48% | -194.23% | -370.02% |
D&A (Non-Cash Add-back) | 411 | 2.21K | 8.39K | 10.57K | 371.75K | 271.8K |
EBIT | 330.55K | 269.56K | 1.21M | 1.78M | 4.19M | -526.29K |
Net Interest Income | -5.27K | -9.96K | -20.9K | 34.91K | 317.36K | 407.7K |
Interest Income | 0 | 0 | 0 | 76.1K | 363.31K | 478.05K |
Interest Expense | 5.27K | 9.96K | 20.9K | 41.19K | 45.96K | 70.35K |
Other Income/Expense | -5.27K | -9.17K | -5.41K | 18K | 6.15M | 5.32M |
Pretax Income | 325.28K▲ 0% | 259.6K▼ 20.2% | 1.19M▲ 358.6% | 1.74M▲ 45.8% | 4.15M▲ 139.0% | -1.46M▲ 0% |
Pretax Margin % | 2.53% | 1.61% | 4.22% | 3.58% | 12.64% | -1.59% |
Income Tax | 21.22K | 15.01K | 220.65K | 443.58K | 270.74K | 1.02M |
Effective Tax Rate % | 6.52% | 5.78% | 18.54% | 25.56% | 6.53% | -69.62% |
Net Income | 304.06K▲ 0% | 244.59K▼ 19.6% | 969.75K▲ 296.5% | 1.29M▲ 33.2% | 3.88M▲ 200.1% | -2.47M▲ 0% |
Net Margin % | 2.37% | 1.51% | 3.44% | 2.66% | 11.82% | -2.7% |
Net Income Growth % | - | -19.56% | 296.49% | 33.2% | 200.13% | -233.6% |
Net Income (Continuing) | 304.06K | 244.59K | 969.75K | 1.29M | 3.88M | -2.47M |
Discontinued Operations | 0 | 0 | 0 | 0 | 0 | 0 |
Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 |
EPS (Diluted) | 0.03▲ 0% | 0.02▼ 20.0% | 0.09▲ 266.7% | 1.06▲ 1104.5% | 1.32▲ 24.5% | -0.55▲ 0% |
EPS Growth % | - | -20% | 266.67% | 1104.55% | 24.53% | -149.39% |
EPS (Basic) | 0.03 | 0.02 | 0.09 | 1.06 | 1.66 | - |
Diluted Shares Outstanding | 10M | 10M | 11.05M | 12.24M | 2.4M | 4.49M |
Basic Shares Outstanding | 10M | 10M | 11.05M | 12.24M | 2.33M | 4.49M |
Dividend Payout Ratio | - | - | - | - | - | - |
HAO Balance Sheet
Haoxi Health Technology Limited (HAO) balance sheet — assets, liabilities & shareholders' equity
| Metric | Jun'21 | Jun'22 | Jun'23 | Jun'24 | Jun'25 | TTM |
|---|---|---|---|---|---|---|
Total Current Assets | 2.63M | 445.06K | 3.67M | 15.38M | 19.6M | 15.32M |
Cash & Short-Term Investments | 55.89K | 293.51K | 1.2M | 6.66M | 8.62M | 6.8M |
Cash Only | 55.89K | 293.51K | 1.2M | 6.66M | 8.62M | 6.8M |
Short-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 |
Accounts Receivable | 1.97M | 3.92K | 66.22K | 3.55M | 5.29M | 1.15M |
Days Sales Outstanding | 56.01 | 0.09 | 0.86 | 26.7 | 58.82 | 10.89 |
Inventory | 471.46K | 0 | 2.4M | 5.17M | 0 | 0 |
Days Inventory Outstanding | 14.06 | - | 33.54 | 41.26 | - | - |
Other Current Assets | -342.24K | 0 | 0 | -5.17M | 0 | 0 |
Total Non-Current Assets | 185.63K | 97.94K | 790.13K | 126.74K | 1.99M | 5.34M |
Property, Plant & Equipment | 185.63K | 97.94K | 233.38K | 126.74K | 188.09K | 143.51K |
Fixed Asset Turnover | 69.21x | 164.97x | 120.96x | 382.82x | 174.41x | 528.16x |
Goodwill | 0 | 0 | 0 | 0 | 0 | 0 |
Intangible Assets | 0 | 0 | 0 | 0 | 1.8M | 694.67K |
Long-Term Investments | 0 | 0 | 0 | 0 | 0 | 4.5M |
Other Non-Current Assets | 0 | 0 | 556.75K | 0 | 0 | 0 |
Total Assets | 2.81M▲ 0% | 542.99K▼ 80.7% | 4.46M▲ 722.2% | 15.51M▲ 247.4% | 21.6M▲ 39.3% | 20.66M▲ 0% |
Asset Turnover | 4.57x | 29.76x | 6.32x | 3.13x | 1.52x | 4.59x |
Asset Growth % | - | -80.7% | 722.15% | 247.35% | 39.27% | 537.61% |
Total Current Liabilities | 4.68M | 2.01M | 2.58M | 3.87M | 3.89M | 4.44M |
Accounts Payable | 2.92M | 1.27M | 27.34K | 653.69K | 153.87K | 162.68K |
Days Payables Outstanding | 87.19 | 29.93 | 0.38 | 5.21 | 1.76 | 1.71 |
Short-Term Debt | 178.82K | 439.4K | 511.41K | 833.52K | 1.69M | 1.31M |
Deferred Revenue (Current) | 542.44K | 166.9K | 1.49M | 1.19M | 537.65K | 3.67M |
Other Current Liabilities | 880.29K | 0 | 0 | 102.44K | 166.55K | 1.41K |
Current Ratio | 0.56x | 0.22x | 1.43x | 3.98x | 5.05x | 3.45x |
Quick Ratio | 0.46x | 0.22x | 0.49x | 2.64x | 5.05x | 3.45x |
Cash Conversion Cycle | -17.13 | - | 34.02 | 62.75 | - | 9.17 |
Total Non-Current Liabilities | 68.56K | 0 | 321.21K | 368.04K | 333.82K | 266.05K |
Long-Term Debt | 0 | 0 | 249.11K | 368.04K | 307.32K | 266.05K |
Capital Lease Obligations | 68.56K | 0 | 0 | 0 | 0 | 0 |
Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Liabilities | 0 | 0 | 72.1K | 0 | 26.5K | 0 |
Total Liabilities | 4.74M | 2.01M | 2.9M | 4.23M | 4.22M | 4.7M |
Total Debt | 335.03K | 505.4K | 850.06K | 1.2M | 1.99M | 1.6M |
Net Debt | 1.09M | 211.89K | -353.14K | -5.45M | -6.62M | -5.2M |
Debt / Equity | - | - | 0.54x | 0.11x | 0.11x | 0.10x |
Debt / EBITDA | 1.01x | 1.87x | 0.71x | 0.70x | - | -0.27x |
Net Debt / EBITDA | 3.29x | 0.78x | -0.29x | -3.16x | - | 0.89x |
Interest Coverage | 62.72x | 27.06x | 57.95x | 43.13x | 91.25x | -7.48x |
Total Equity | -1.93M▲ 0% | -1.47M▲ 24.1% | 1.57M▲ 206.9% | 11.27M▲ 619.6% | 17.38M▲ 54.2% | 15.96M▲ 0% |
Equity Growth % | - | 24.1% | 206.88% | 619.56% | 54.16% | 1647.43% |
Book Value per Share | -0.19 | -0.15 | 0.14 | 0.92 | 7.25 | 3.56 |
Total Shareholders' Equity | -1.93M | -1.47M | 1.57M | 11.27M | 17.38M | 15.96M |
Common Stock | 2.54K | 2.54K | 2.95K | 3.22K | 7.24K | 148.61K |
Retained Earnings | -1.78M | -1.54M | -568.46K | 723.21K | 4.6M | -2.28M |
Treasury Stock | 0 | 0 | 0 | 0 | 0 | 0 |
Accumulated OCI | -176K | -112.96K | -44.78K | -44.39K | -45.52K | 67.97K |
Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 |
HAO Cash Flow Statement
Haoxi Health Technology Limited (HAO) cash flow — operating, investing & free cash flow history
| Metric | Jun'21 | Jun'22 | Jun'23 | Jun'24 | Jun'25 | TTM |
|---|---|---|---|---|---|---|
Cash from Operations | 2.65M | -675.36K | -872.13K | -747.58K | -3.36M | -6.67M |
Operating CF Margin % | 20.62% | -4.18% | -3.09% | -1.54% | -10.24% | - |
Operating CF Growth % | - | -125.5% | -29.14% | 14.28% | -349.2% | -851.33% |
Net Income | 304.06K | 244.59K | 969.75K | 1.29M | 3.88M | -2.47M |
Depreciation & Amortization | 411 | 2.21K | 8.39K | 10.57K | 371.75K | 271.8K |
Stock-Based Compensation | 0 | 0 | 0 | 0 | 0 | 0 |
Deferred Taxes | 0 | 0 | 0 | 0 | 0 | 0 |
Other Non-Cash Items | 3.36M | -1.63M | -1.85M | 1.33M | -5.76M | 1.51M |
Working Capital Changes | -1.02M | 710.99K | -1.85M | -2.05M | -1.84M | -5.98M |
Change in Receivables | -295.26K | 665.62K | -4.28K | -217.9K | -253.99K | -767.4K |
Change in Inventory | 0 | 0 | 0 | 0 | 0 | 0 |
Change in Payables | 2.71M | -1.6M | -1.2M | 623.17K | -496.83K | -837.91K |
Cash from Investing | -3.26K | -8.7K | -45.5K | -3.13M | -3.58M | -11.19M |
Capital Expenditures | -3.26K | -8.7K | -45.5K | -55.37K | -2.08M | -2.12M |
CapEx % of Revenue | 0.03% | 0.05% | 0.16% | 0.11% | 6.34% | 2.31% |
Acquisitions | 0 | 0 | 0 | 0 | 0 | 0 |
Investments | - | - | - | - | - | - |
Other Investing | 0 | 0 | 0 | -3.07M | -1.5M | -1.5M |
Cash from Financing | -2.61M | 933.22K | 1.8M | 9.32M | 8.9M | 22.91M |
Debt Issued (Net) | -1.34M | 769.3K | 366.83K | 362.47K | 785.3K | 505.6K |
Equity Issued (Net) | 0 | 163.92K | 1.99M | 8.98M | 8.12M | 22.41M |
Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 |
Share Repurchases | 0 | 0 | 0 | 0 | 0 | 0 |
Other Financing | -1.27M | 0 | -558.52K | -14.33K | 0 | -1 |
Net Change in Cash | 35.56K▲ 0% | 237.63K▲ 568.3% | 909.69K▲ 282.8% | 5.45M▲ 499.4% | 1.96M▼ 64.0% | 5.69M▲ 0% |
Free Cash Flow | 2.65M▲ 0% | -684.06K▼ 125.9% | -917.63K▼ 34.1% | -802.94K▲ 12.5% | -3.36M▼ 318.2% | -6.71M▲ 0% |
FCF Margin % | 20.59% | -4.23% | -3.25% | -1.65% | -10.24% | -7.32% |
FCF Growth % | - | -125.86% | -34.15% | 12.5% | -318.22% | -588.59% |
FCF per Share | 0.26 | -0.07 | -0.08 | -0.07 | -1.40 | -1.50 |
FCF Conversion (FCF/Net Income) | 8.71x | -2.76x | -0.90x | -0.58x | -0.87x | 2.71x |
Interest Paid | 8.18K | 206 | 0 | 37.27K | 0 | 0 |
Taxes Paid | 1.78K | 7.39K | 0 | 27.57K | 0 | 0 |
HAO Key Ratios
Haoxi Health Technology Limited (HAO) financial ratios — P/E, ROE, debt and 30+ core market and balance-sheet ratios
| Metric | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
Return on Equity (ROE) | - | 1923.73% | 20.12% | 27.06% | -15.63% |
Return on Invested Capital (ROIC) | - | 73.92% | 36.64% | -18.1% | -48.23% |
Gross Margin | 4.02% | 7.3% | 5.67% | 2.83% | 4.44% |
Net Margin | 1.51% | 3.44% | 2.66% | 11.82% | -2.7% |
Debt / Equity | - | 0.54x | 0.11x | 0.11x | 0.10x |
Interest Coverage | 27.06x | 57.95x | 43.13x | 91.25x | -7.48x |
FCF Conversion | -2.76x | -0.90x | -0.58x | -0.87x | 2.71x |
Revenue Growth | 25.76% | 74.72% | 71.88% | -32.39% | 53.23% |
Related:HAO Dividend History·HAO Revenue History·HAO Price History·HAO P/E History·HAO Financial Ratios·HAO Institutional Holders
HAO Frequently Asked Questions
Haoxi Health Technology Limited (HAO) stock FAQ — growth, dividends, profitability & financials explained
Growth & Financials
Haoxi Health Technology Limited (HAO) reported $91.6M in revenue for fiscal year 2025. This represents a 613% increase from $12.8M in 2021.
Haoxi Health Technology Limited (HAO) saw revenue decline by 32.4% over the past year.
Haoxi Health Technology Limited (HAO) reported a net loss of $2.5M for fiscal year 2025.
Dividend & Returns
Haoxi Health Technology Limited (HAO) has a return on equity (ROE) of 27.1%. This is excellent, indicating efficient use of shareholder capital.
Haoxi Health Technology Limited (HAO) had negative free cash flow of $6.7M in fiscal year 2025, likely due to heavy capital investments.